Development of 8-benzyloxy-substituted quinoline ethers and evaluation of their antimicrobial activities

Medicinal Chemistry Research

Volumn 24, Issue 4, 2015, Pages 1568-1577

  Chung, Po Yee ^a   Gambari, Roberto ^b   Chen, Yi Xin ^c   Cheng, Chor Hing ^a   Bian, Zhao Xiang ^d   Chan, Albert Sun Chi ^d   Tang, Johnny Cheuk On ^a   Leung, Polly Hang Mei ^a   Chui, Chung Hin ^d   Lam, Kim Hung ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF FERRARA   (Italy)

^c GUANGZHOU UNIVERSITY   (China)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

8 Hydroxyquinoline; A549 cells; Antimicrobial; Aspergillus niger

Indexed keywords

8 (2 BROMOBENZYLOXY) QUINOLINE; 8 (3 BROMOBENZYLOXY) QUINOLINE; 8 (3 METHOXYBENZYLOXY) QUINOLINE; 8 (3 METHYLBENZYLOXY) QUINOLINE; 8 (3 NITROBENZYLOXY) QUINOLINE; 8 (3 PHENYLBENZYLOXY) QUINOLINE; 8 (3,5 BIS (TRIFLUOROMETHYL)BENZYLOXY) QUINOLINE; 8 (4 (TRIFLOROMETHYL)BENZYLOXY) QUINOLINE; 8 (4 (TRIFLUOROMETHOXY)BENZYLOXY) QUINOLINE; 8 (4 BROMOBENZYLOXY) QUINOLINE; 8 (4 CHLOROBENZYLOXY) QUINOLINE; 8 (4 FLUOROBENZYLOXY) QUINOLINE; 8 (4 NITROBENZYLOXY) QUINOLINE; 8 (BENZYLOXY) QUINOLINE; 8 QUINOLINOL; QUINOLINE DERIVATIVE; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84943015111     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-014-1217-4     Document Type: Article

References (42)

1. Albrecht M, Osetska O, Frohlich R (2006) The hiratani-double-clasien rearrangment as a key step in the preparationn of sequential bis(8-hydroxyquinoline) ligands. Synlett 6:924-926
2. Banerjee M, Kumar S, Ghosh S, Paira R, Mondal S, Karmokar S, Chattopadhyay D, Bhadra RK, Mondal NB (2014) Amberlite IRA 402(OH)-mediated synthesis and evaluation of fused tricyclic quinolinium salts as potent non-detergent type microbicidal spermicides. Med Chem Res 23:1488-1500
3. Bringmann G, Thomale K, Bischof S, Schneider C, Schultheis M, Schwarz T, Moll H (2013) A novel leishmania major Amastigote assay in 96-well format for rapid drug screening and its use for discovery and evaluation of a new class of leishmanicidal quinolinium salts. Antimicrob Agents Chemother 57:3003-3011
4. Chan SH, Chui CH, Chan SW, Kok SHL, Chan D, Tsoi MYT, Leung PHM, Lam AKY, Chan ASC, Lam KH, Tang JCO (2013) Synthesis of 8-hydroxyquinoline derivatives as novel anti-tumor agents. ACS Med Chem Lett 4:170-174
5. Chen ZF, Wei JH, Liu YC, Liu M, Gu YQ, Huang KB, Wang M, Liang H (2013) High antitumor activity of 5,7-dihalo-8-quinolinolato cerium complexes. Eur J Med Chem 68:454-462
6. Denton JR (2010) One-Pot Desulfonylative Alkylation of N-Sulfonyl Azacycles Using Alkoxides Generated by Phase-Transfer Catalysis. Synthesis 5:775-782
7. El-Agrody AM, Abd-Rabboh HSM, Al-Ghamdi AM (2013) Synthesis, antitumor activity, and structure-activity relationship of some 4H-pyrano[3,2-h]quinoline and 7H-pyrimido[4′5′:6,5]pyrano[3,2-h]quinoline derivatives. Med Chem Res 22:1339-1355
8. Ewa B, Maciej W, Marcin S, Grzegorz D, Michał Z, Jan P, Józef O (2012) The development of first Staphylococcus aureus SplB protease inhibitors: Phosphonic analogues of glutamine. Bioorg Med Chem Lett 22:5574-5578
9. He X, Zhong M, Zhang T, Yang J, Wu Z, Xiao Y, Guo H, Qiu G, Hu X (2012) Synthesis and anticonvulsant activity of 1-(8-(benzyloxy)quinolin-2-yl)-6-substituted-4,6-diazaspiro[2,4]heptane-5,7-diones. Eur J Med Chem 48:338-346
10. Johnson JR, Russo TA, Drawz SM, Clabots C, Olson R, Kuskowski MA, Rosen H (2013) OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K +:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis. Microb Pathog 64:1-5
11. Kaur K, Jain M, Reddy RP, Jain R (2010) Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 45:3245-3264
12. Kerr KG, Snelling AM (2009) Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 72:338-344
13. Ko TC, Hour MJ, Lien JC, Teng CM, Lee KH, Kuo SC, Huang LJ (2001) Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. Bioorg Med Chem Lett 11:279-282
14. Krishnakumar V, Nawaz Khan FR, Mandal BK, Mitta S, Dhasamandha R, Govindan VN (2012) Quinoline-3-carboxylates as potential antibacterial agents. Res Chem Intermed 38:1819-1826
15. Kunitoshi T, Taro T, Minako H, Kohdoh S, Ryota T, Kaoru MT, Masae F, Yoshinori T, Kogyoku S, Mitsuhiro I, Hisashi S, Masahiro Y (2012) Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: potent, orally active corticotrophin-releasing factor-1-receptor antagonists. Bioorg Med Chem 20:6559-6578
16. Kuwabara H, Shibayama Y (2012) Pulmonary aspergilloma with prominent oxalate deposition. Indian J Pathol Microbiol 55:589-590
17. Lam KH, Gambari R, Lee KKH, Chen YX, Kok SHL, Wong RSM, Lau FY, Cheng CH, Wong WY, Bian ZX, Chan ASC, Tang JCO, Chui CH (2014a) Preparation of 8-hydroxyquinoline derivatives as potential antibiotics against Staphylococcus aureus. Bioorg Med Chem Lett 24:367-370
18. Lam PL, Lu GL, Hon KM, Lee KW, Ho CL, Wang X, Tang JCO, Lam KH, Wong RSM, Kok SHL, Bian ZX, Li H, Lee KKH, Gambari R, Chui CH, Wong WY (2014b) Development of ruthenium(II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus. Dalton Trans 43:3949-3957
19. Lam PL, Kok SHL, Bian ZX, Lam KH, Tang JCO, Lee KKH, Gambari R, Chui CH (2014c) D-glucose as amodifying agent in gelatin/collagen matrix and reservoir nanoparticles for Calendula officinalis delivery. Colloids Surf B Biointerfaces 117:277-283
20. Landini D, Maia A, Rampoldi A (1986) Stability of quaternary onium salts under phase-transfer conditions in the presence of aqueous alkaline solutions. J Org Chem 51:3187-3191
21. Liu TC, Wang ML (2008) Kinetic study of S-alkylation of 2-mercaptobenzimidazole catalyzed by tetrabutylammonium bromide. Chem Eng Comm 196:530-548
22. Lowy FD (1998) Staphylococcus aureus infections. New Engl J Med 339:520-532
23. Melissa OX, Sales MDPU, Camargo JDJP, Pasqualotto AC, Severo LC (2008) Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report. Rev Soc Bras Med Trop 41:200-201
24. Oda M, Saraya T, Wakayama M, Shibuya K, Ogawa Y, Inui T, Yokoyama E, Inoue M, Shimoyamada H, Fujiwara M, Ota T, Takizawa H, Goto H (2013) Calcium oxalate crystal deposition in a patient with Aspergilloma due to Aspergillus niger. J Thorac Dis 5:E174-E178
25. Otto M (2009) Staphylococcus epidermidis - the 'accidental' pathogen. Nat Rev Microbiol 7:555-567
26. Parthiban P, Aridos G, Rathika P, Ramkumar V, Kabilan S (2009) Synthesis, spectral, crystal and antimicrobial studies of biologically potent oxime ethers of nitrogen, oxygen and sulfur heterocycles. Bioorg Med Chem Lett 19:2981-2985
27. Procop GW, Johnston WW (1997) Diagnostic value of conidia associated with pulmonary oxalosis: evidence of an Aspergillus niger infection. Diagn Cytopathol 17:292-294
28. Roehrl MHA, Croft WJ, Liao Q, Wang JY, Kradin RL (2007) Hemorrhagic pulmonary oxalosis secondary to a noninvasive Aspergillus niger fungus ball. Virchows Arch 451:1067-1073
29. Rojas Ruiz FA, García-Sánchez RN, Estupiñan SV, Gómez-Barrio A, Torres Amado DF, Pérez-Solórzano BM, Nogal-Ruiz JJ, Martínez-Fernández AR, Kouznetsov VV (2011) Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds. Bioorg Med Chem 19:4562-4573
30. Sahu KB, Ghosh S, Banerjee M, Maity A, Mondal S, Paira R, Saha P, Naskar S, Hazra A, Banerjee S, Samanta A, Mondal NB (2013) Synthesis and in vitro study of antibacterial, antifungal activities of some novel bisquinolines. Med Chem Res 22:94-104
31. Shi A, Nguyen TA, Battina SK, Rana S, Takemoto DJ, Chiang PK, Hua DH (2008) Synthesis and anti-breast cancer activities of substituted quinolines. Bioorg Med Chem Lett 18:3364-3368
32. Singh N, Paterson DL (2005) Aspergillus infections in transplant recipients. Clin Microbiol Rev 18:44-69
33. Tavares LC, Johann S, Almeida Alves TM, Guerra JC, Souza-Fagundes M, Cisalpino PS, Bortoluzzi AJ, Caramori GF, Piccoli RDM, Braibante HTS, Braibante MEF, Pizzolatti MG (2011) Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities. Eur J Med Chem 46:4448-4456
34. Vandekerckhove S, Tran HG, Desmet T, D'hooghe M (2013) Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents. Bioorg Med Chem Lett 23:4641-4643
35. Verkade E, Kluytmans J (2014) Livestock-associated Staphylococcus aureus CC398: Animal reservoirs and human infections. J Infect Genet Evol 21:523-530
36. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, Burik JAV, Wingard JR, Patterson TF (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327-360
37. Weiser R, Donoghue D, Weightman A, Mahenthiralingam E (2014) Evaluation of five selective media for the detection of Pseudomonas aeruginosa using a strain panel from clinical, environmental and industrial sources. J Microbiol Methods 99:8-14
38. Wu Y, Chen Z, Liu Y, Yu L, Zhou L, Yang S, Lai L (2011) Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors. Bioorg Med Chem 19:3266-3361
39. Xu H, Jian KZ, Guan Q, Ye F, Lv M (2007) Antifungal activity of some diaryl ethers. Chem Pharmaceut Bull 55:1755-1757
40. Yadav GD, Bisht PM (2004) Selectivity engineering in multiphase transfer catalysis in the preparation of aromatic ethers. J Mol Catal A 223:93-100
41. Yadav GD, Desai NM (2006) Phase transfer catalysed alkylation of 2′hydroxy acetophenone with 1-bromopentane: Kinetics and mechanism of liquid-liquid reaction. J Mol Catal A 243:278-285
42. Ziebuhr W, Hennig S, Eckart M, Kränzler H, Batzilla C, Kozitskaya S (2006) Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int J Antimicrob Agents 28:14-20